v3.19.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net income $ 42,222 $ 54,105
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 32,234 32,966
Amortization of debt issuance costs and debt discount 930 931
Gain from insurance recoveries, net (1,513) 0
Loss on intangible asset impairment 2,911 0
Losses from equity method investment 603 1,148
Amortization of deferred gain on terminated swaps (873) (632)
Share-based compensation 1,706 2,459
Deferred taxes 0 (457)
Change in assets and liabilities:    
Trade receivables (4,678) (914)
Inventories (3,190) (7,627)
Prepaid expenses and other current assets 12,453 1,264
Accounts payable (16,451) (52)
Accrued and other current liabilities (433) 1,089
Other long-term liabilities (176) (226)
Net cash provided by operating activities 65,745 84,054
Cash flows from investing activities:    
Payments for property, plant and equipment (19,287) (19,761)
Payments for intangible assets (1,551) (1,359)
Proceeds from insurance recoveries 1,589 125
Capital contributions to equity method investment (407) (548)
Distributions from equity method investment 564 468
Net cash used in investing activities (19,092) (21,075)
Cash flows from financing activities:    
Proceeds from exercise of stock options 118 145
Tax withholdings on share-based compensation (1,165) (547)
Principal payments for debt (2,037) (2,037)
Payments to repurchase common stock (20,023) (27,425)
Net cash used in financing activities (23,107) (29,864)
Effect of foreign exchange rates on cash and cash equivalents 254 (184)
Net change in cash and cash equivalents 23,800 32,931
Cash, beginning of period 102,633 72,521
Cash, end of period $ 126,433 $ 105,452